Pharmaceutical Working Group Go back »

The Pharmaceutical Working Group is comprised of 38 foreign pharmaceutical manufacturing companies. All members are committed to cooperating closely with Chinese healthcare stakeholders, in order to establish a competitive healthcare system which serves all Chinese patients. As such, the Working Group strongly welcomes the initiatives made for the long-term, which will substantially benefit both Chinese patients and the Chinese economy. The technology transferred from Europe further demonstrates the commitment these companies make in supporting China’s goal to become an innovative society by 2020.

  • Chair: Ms. Yingrong Du
  • Vice Chair: Ms. Li Ye, Mr. Xuan Cui

Related Lobby Actions View all »


Comments on the CFDA's draft "Provision on Overseas Audit of Pharmaceutical and Medical Device Plants"

Read more


Comments on CFDA & NHFPC's Administrative Measures for Medical Representative Filing and Registration

Read more

Related EURObiz articles

You are currently not a member of this Working Group.

Join this Working Group

Chamber contact
Xiaochen Ni
Xiaochen Ni


Xiaochen Ni
Xiaochen Ni


Quick jump to:

Back to overview